Plasma α-tocopherol concentrations after supplementation with water- and fat-soluble vitamin E

Abstract

The objective of this study was to examine differences in plasma α- tocopherol concentrations after oral administration of pharmacologic doses of vitamin E to normal healthy subjects as RRR-α-tocopheryl glycol 1000 succinate (TPGS; water-miscible form) and RRR-α-tocopheryl acetate (TA; fat- soluble form). The study was designed to evaluate the administration of three different single doses and multiple doses for 4 wk with both preparations. Administration of 400 IU (269 mg), 800 IU (537 mg), and 1200 IU (807 mg) TPGS as a single dose resulted in slight elevation of plasma α-tocopherol concentrations. Administration of multiple daily doses at all three amounts of TPGS for 28 consecutive days resulted in a slight elevation of plasma α- tocopherol concentrations. A significant increase in plasma α-tocopherol concentrations was observed after ingestion of a single dose or equivalent multiple doses of TA at all three doses. As reported in the literature, in cases of cholestasis and other forms of lipid malabsorption, oral administration of TPGS is the treatment of choice. It appears that for normal adults and patients with normal lipid absorption, fat-soluble forms of vitamin E are preferable for therapeutic and prophylactic uses.